Standard BioTools Total Current Assets 2010-2025 | LAB
Standard BioTools total current assets from 2010 to 2025. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
| Standard BioTools Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $376 |
| 2023 | $158 |
| 2022 | $209 |
| 2021 | $72 |
| 2020 | $118 |
| 2019 | $96 |
| 2018 | $127 |
| 2017 | $95 |
| 2016 | $97 |
| 2015 | $144 |
| 2014 | $156 |
| 2013 | $105 |
| 2012 | $101 |
| 2011 | $70 |
| 2010 | $21 |
| 2009 | $28 |
| Standard BioTools Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $344 |
| 2024-12-31 | $376 |
| 2024-09-30 | $454 |
| 2024-06-30 | $480 |
| 2024-03-31 | $548 |
| 2023-12-31 | $158 |
| 2023-09-30 | $171 |
| 2023-06-30 | $183 |
| 2023-03-31 | $195 |
| 2022-12-31 | $209 |
| 2022-09-30 | $229 |
| 2022-06-30 | $251 |
| 2022-03-31 | $73 |
| 2021-12-31 | $72 |
| 2021-09-30 | $73 |
| 2021-06-30 | $78 |
| 2021-03-31 | $96 |
| 2020-12-31 | $118 |
| 2020-09-30 | $123 |
| 2020-06-30 | $78 |
| 2020-03-31 | $82 |
| 2019-12-31 | $96 |
| 2019-09-30 | $97 |
| 2019-06-30 | $107 |
| 2019-03-31 | $111 |
| 2018-12-31 | $127 |
| 2018-09-30 | $72 |
| 2018-06-30 | $75 |
| 2018-03-31 | $81 |
| 2017-12-31 | $95 |
| 2017-09-30 | $96 |
| 2017-06-30 | $79 |
| 2017-03-31 | $86 |
| 2016-12-31 | $97 |
| 2016-09-30 | $108 |
| 2016-06-30 | $127 |
| 2016-03-31 | $138 |
| 2015-12-31 | $144 |
| 2015-09-30 | $145 |
| 2015-06-30 | $143 |
| 2015-03-31 | $155 |
| 2014-12-31 | $156 |
| 2014-09-30 | $133 |
| 2014-06-30 | $127 |
| 2014-03-31 | $179 |
| 2013-12-31 | $105 |
| 2013-09-30 | $87 |
| 2013-06-30 | $81 |
| 2013-03-31 | $99 |
| 2012-12-31 | $101 |
| 2012-09-30 | $106 |
| 2012-06-30 | $56 |
| 2012-03-31 | $57 |
| 2011-12-31 | $70 |
| 2011-09-30 | $76 |
| 2011-06-30 | $81 |
| 2011-03-31 | $91 |
| 2010-12-31 | $21 |
| 2010-09-30 | $18 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.395B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.234B | 52.81 |
| Hims & Hers Health (HIMS) | United States | $12.982B | 134.88 |
| Tempus AI (TEM) | United States | $10.012B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.465B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.309B | 67.32 |
| Privia Health (PRVA) | United States | $2.902B | 198.33 |
| Enovis (ENOV) | United States | $1.848B | 10.30 |
| Clover Health Investments (CLOV) | United States | $1.791B | 0.00 |
| Schrodinger (SDGR) | United States | $1.498B | 0.00 |
| Phreesia (PHR) | United States | $1.456B | 0.00 |
| Omnicell (OMCL) | United States | $1.281B | 22.59 |
| Azenta (AZTA) | United States | $1.258B | 58.47 |
| 10x Genomics (TXG) | United States | $1.024B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.534B | 0.00 |
| Talkspace (TALK) | United States | $0.486B | 145.25 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Claritev (CTEV) | United States | $0.473B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 805.00 |
| Nyxoah SA (NYXH) | Belgium | $0.274B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.141B | 0.00 |
| Pulmonx (LUNG) | United States | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| 111 (YI) | China | $0.067B | 0.00 |
| Outset Medical (OM) | United States | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |